Insights

Innovative Technology Limula offers a proprietary, end-to-end automated platform for cell therapy manufacturing, streamlining processes and reducing complexity, which can appeal to pharmaceutical companies seeking scalable and efficient biomanufacturing solutions.

Recent Market Entry With the launch of LimONE and recent investments totaling over 7.3 million USD, Limula is positioned as a disruptive innovator in cell and gene therapy, presenting opportunities to partner with biotech firms aiming to adopt cutting-edge manufacturing technologies.

Strong Industry Recognition Winning the BioTools Innovator Grand Prize and receiving multiple grants indicates high credibility and validation from industry experts, making Limula an attractive partner for research institutions and clinical developers seeking reliable tech solutions.

Funding Growth Potential The company has secured significant seed funding to scale its platform, signaling strong growth potential and openings for collaborations with investors or firms interested in early-stage innovative biotech manufacturing technology.

Focus on Personalized Treatments Limula specializes in personalized cancer treatment solutions at scale, offering opportunities to align with pharmaceutical and biotech companies focused on precision medicine and custom therapies.

Limula Tech Stack

Limula uses 8 technology products and services including SOLIDWORKS, RSS, Beaver Builder, and more. Explore Limula's tech stack below.

  • SOLIDWORKS
    Cad & Graphics
  • RSS
    Content Management System
  • Beaver Builder
    Content Management System
  • MySQL
    Database
  • imagesLoaded
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • HSTS
    Security
  • HTTP/3
    Web & Portal Technology

Media & News

Limula's Email Address Formats

Limula uses at least 1 format(s):
Limula Email FormatsExamplePercentage
First.Last@limula.chJohn.Doe@limula.ch
46%
FirstMiddle.Last@limula.chJohnMichael.Doe@limula.ch
4%
First.Last@limula.chJohn.Doe@limula.ch
46%
FirstMiddle.Last@limula.chJohnMichael.Doe@limula.ch
4%

Frequently Asked Questions

What is Limula's official website and social media links?

Minus sign iconPlus sign icon
Limula's official website is limula.ch and has social profiles on LinkedInCrunchbase.

What is Limula's SIC code NAICS code?

Minus sign iconPlus sign icon
Limula's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Limula have currently?

Minus sign iconPlus sign icon
As of January 2026, Limula has approximately 29 employees across 1 continents, including Europe. Key team members include Ceo And Co-Founder: L. H.Coo And Co-Founder: T. E.Head Of Operations: O. W.. Explore Limula's employee directory with LeadIQ.

What industry does Limula belong to?

Minus sign iconPlus sign icon
Limula operates in the Biotechnology Research industry.

What technology does Limula use?

Minus sign iconPlus sign icon
Limula's tech stack includes SOLIDWORKSRSSBeaver BuilderMySQLimagesLoadedMicrosoftHSTSHTTP/3.

What is Limula's email format?

Minus sign iconPlus sign icon
Limula's email format typically follows the pattern of First.Last@limula.ch. Find more Limula email formats with LeadIQ.

How much funding has Limula raised to date?

Minus sign iconPlus sign icon
As of January 2026, Limula has raised $566K in funding. The last funding round occurred on Dec 11, 2024 for $566K.

When was Limula founded?

Minus sign iconPlus sign icon
Limula was founded in 2020.

Limula

Biotechnology ResearchVaud, Switzerland11-50 Employees

Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics.

Section iconCompany Overview

Website
limula.ch
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $566K

    Limula has raised a total of $566K of funding over 13 rounds. Their latest funding round was raised on Dec 11, 2024 in the amount of $566K.

  • $1M

    Limula's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $566K

    Limula has raised a total of $566K of funding over 13 rounds. Their latest funding round was raised on Dec 11, 2024 in the amount of $566K.

  • $1M

    Limula's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.